Faculty of Veterinary Science, The University of Sydney, 425 Werombi Road, Camden, 2570 NSW, Australia.
Prev Vet Med. 2013 Aug 1;111(1-2):81-91. doi: 10.1016/j.prevetmed.2013.03.003. Epub 2013 Apr 8.
This study was conducted to evaluate the effectiveness of Gudair™ vaccine in decreasing the prevalence of shedding of Mycobacterium avium subsp. paratuberculosis (MAP) in flocks of varying initial prevalence. Thirty-seven self-replacing Merino flocks from New South Wales and Victoria (Australia) that had been vaccinating lambs with Gudair™ for at least five years were enrolled in the study. These flocks had been tested prior to or at commencement of vaccination using pooled faecal culture, agar gel immunodiffusion or both tests. These pre-vaccination test results were used to estimate pre-vaccination prevalence. Post-vaccination prevalence was estimated from culture of usually 7 pools of 50 sheep collected from the enrolled flocks in 2008-2009, approximately five or more years after commencement of vaccination. A Bayesian model was developed to estimate and compare the pre- and post-vaccination prevalences for the enrolled flocks. Apparent pre- and post-vaccination prevalences for flocks were modelled as functions of the true pre- and post-vaccination prevalences, respectively, and the sensitivities and specificities of the respective diagnostic tests. Logit-normal models were specified on pre- and post-vaccination true prevalences and were then used to make inferences about the median and 90th percentile of the prevalence distributions and their differences. Priors were mostly specified based on published literature or analysis of abattoir surveillance data for this population of flocks. The analysis found a significant decline in ovine Johne's disease prevalence from a pre-vaccination median prevalence of 2.72% [95% probability interval (PI): 1.40; 6.86%] to a post-vaccination median prevalence of 0.72% (0.39; 1.27%). However 30 of the 37 flocks still contained sheep that were shedding MAP in their faeces. The results suggest that vaccination with Gudair™ is usually effective in reducing the prevalence of faecal shedding but the response to vaccination is variable among flocks. The Bayesian approach reported here could be implemented in similar situations to compare prevalences where information from multiple diagnostic tests with varied sensitivities and specificities is available.
本研究旨在评估 Gudair™ 疫苗在降低不同初始流行率的羊群中分枝杆菌 avium subsp. paratuberculosis (MAP) 脱落率方面的有效性。37 个来自新南威尔士州和维多利亚州(澳大利亚)的自繁美利奴羊场参加了这项研究,这些羊场至少五年来一直在给羔羊接种 Gudair™ 疫苗。这些羊群在接种疫苗前或接种疫苗时使用粪便混合培养、琼脂凝胶免疫扩散或两种检测方法进行了检测。这些接种前的检测结果用于估计接种前的流行率。接种后的流行率通过 2008-2009 年从参与羊群中采集的通常 7 个 50 只羊的粪便样本的培养来估计,接种疫苗大约五年或更长时间后。建立了贝叶斯模型来估计和比较参与羊群的接种前和接种后的流行率。将羊群的明显接种前和接种后的流行率分别建模为真实接种前和接种后的流行率的函数,以及各自诊断测试的敏感性和特异性。对数正态模型分别用于接种前和接种后真实流行率,并用于推断流行率分布的中位数和第 90 百分位数及其差异。先验大多基于文献或该羊群屠宰场监测数据的分析来指定。分析发现,从接种前的 2.72%[95%概率区间(PI):1.40;6.86%]的中位数流行率到接种后的 0.72%(0.39;1.27%)的中位数流行率,绵羊约翰氏病的流行率显著下降。然而,37 个羊群中有 30 个仍有绵羊粪便中存在 MAP。结果表明,接种 Gudair™ 通常可以有效降低粪便脱落的流行率,但疫苗接种的反应在羊群中存在差异。这里报告的贝叶斯方法可以在类似情况下实施,以比较具有不同敏感性和特异性的多种诊断测试信息的流行率。